Hypertension Journal

Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2016 ) > List of Articles

RESEARCH ARTICLE

Revival of Renal Denervation Therapy for Hypertension: Real Hope or just a Dream?

Venkatesh K Raman, Vasilios Papademetriou

Citation Information : Raman VK, Papademetriou V. Revival of Renal Denervation Therapy for Hypertension: Real Hope or just a Dream?. Hypertens J 2016; 2 (3):160-168.

DOI: 10.5005/jp-journals-10043-0049

Published Online: 01-09-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Raman VK, Papademetriou V. Revival of Renal Denervation Therapy for Hypertension: Real Hope or just a Dream? Hypertens J 2016;2(3):160-168.


PDF Share
  1. Lecons sur les Proprietes physiologiques et les alterations pathologiques des liquides de l'organisme. Vol. 2. Paris: Balliere et Fils; 1859. p. 170-171.
  2. The innervation of the renal blood vessels. J Physiol 1889 Jul;10(5):358-407.
  3. The rat renal nerves during development. Anat Embryol (Berl) 1993 Oct;188(4):345-361.
  4. The production of arterial hypertension by chronic renal artery-nerve stimulation. Am J Physiol 1945 Nov;145(1):38-47.
  5. Functional identification of the central projections of afferent renal nerves. Clin Exp Hypertens A 1987 Jan;9(Suppl 1):47-57.
  6. Do different levels and patterns of sympathetic activation all provoke renal vasoconstriction? J Auton Nerv Syst 1998 Mar;69(1):72-82.
  7. Efferent renal nerve traffic in the spontaneously hypertensive rat. Clin Exp Hypertens A 1987 Jan;9(Suppl 1): 259-279.
  8. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995 Apr;25(4 Pt 2):878-882.
  9. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 1995 Nov;26(5):861-865.
  10. Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension. Am J Hypertens 1990 Jan;3(1):62-64.
  11. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension 1980 May-Jun;2(3):266-273.
  12. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension 1998 Aug;32(2):249-254.
  13. The effect on the kidney of bilateral splanchnicectomy in patients with hypertension. J Clin Invest 1937 Jan;16(1):49-65.
  14. Malignant hypertension: report of case treated by bilateral section of anterior spinal nerve roots from the sixth thoracic to the second lumbar inclusive. JAMA 1934 Apr;102(14):1115-1118.
  15. Some observations on decapsulation and denervation of the kidney. Brit J Urol 1936 Dec;8(4):319-328.
  16. The effect of renal denervation on the level of arterial blood pressure and renal function in essential hypertension. J Clin Invest 1935 Jan;14(1):27-30.
  17. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 1953 Aug;152(16):1501-1504.
  18. Results of bilateral supradiaphragmatic splanch-nicectomy for arterial hypertension. N Engl J Med 1947 Feb;236(8):270-277.
  19. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939 Mar;197(3):332-343.
  20. Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension. Am Heart J 1989 Oct;118(4):775-781.
  21. Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertens 2004 Mar;17(3):217-222.
  22. Transvenous parasympathetic cardiac nerve stimulation: an approach for stable sinus rate control. J Cardiovasc Electrophysiol 1999 Nov;10(11):1517-1524.
  23. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 2000 Nov;102(22):2774-2780.
  24. Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions. Circulation 2014 Apr;129(13):1440-1451.
  25. Renal denervation and Symplicity HTN-3: “Dubium Sapientiae Initium” (Doubt is the beginning of wisdom). Circ Res 2014 Jul;115(2):211-214.
  26. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009 Apr;373(9671):1275-1281.
  27. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010 Dec;376(9756):1903-1909.
  28. Catheter-based renal denervation for resistant hypertension: 12-month results of the Enlig HTN I first-in-human study using a multielectrode ablation system. Hypertension 2014 Sep;64(3):565-572.
  29. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study. Euro Intervention 2015 Feb;10(10):1213-1220.
  30. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the One ShotTM ablation system (RAPID) study. Euro Intervention 2015 Feb;10(10):1221-1229.
  31. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 1999 Sep;341(14):1021-1028.
  32. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 1999 Sep;341(14):1029-1036.
  33. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol 2005 Nov;46(10):1812-1819.
  34. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014 Apr;370(15):1393-1401.
  35. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 2015 Jan;36(4):219-227.
  36. Renal artery nerve distribution and density in the porcine model: biologic implications for the development of radiofrequency ablation therapies. Transl Res 2013 Dec;162(6):381-389.
  37. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 2014 Aug;64(7):635-643.
  38. Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension. Sci Transl Med 2015 Apr;7(285):285ra65.
  39. Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J Am Coll Cardiol 2015 Oct;66(16):1766-1775.
  40. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension 2015 Feb;65(2):393-400.
  41. Next generation renal denervation: chemical “perivascular” renal denervation with alcohol using a novel drug infusion catheter. Cardiovasc Revasc Med 2015 Jun;16(4):221-227.
  42. Renal denervation therapy for hypertension: pathways for moving development forward. J Am Soc Hypertens 2015 May;9(5):341-350.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.